Device/Diagnostics Quarterly Deal Statistics, Q2 2013

In the second quarter of 2013, device companies raised $1.06 billion (45 transactions), on par with the $1.1 billion amassed in the previous quarter for about the same number of deals. (See Exhibit 1.) Late-stage venture financing again led, bringing in $384 million. Top fundraiser Proteus Digital Health Inc. grossed $63 million in a Series F round from corporate backers Oracle Corp., Otsuka Pharmaceutical Co. Ltd., Novartis AG, and return investor Sino Portfolio. [See Deal] Proteus has brought in $180 million since its 2001 inception and in July 2012 received FDA approval for its ingestible sensor device (see[A#01120806010]), capable of communicating physiologic and behavioral data to caregivers via a wireless signal contained in the sensor. The diagnostic imaging field had a decent showing from three firms completing late-stage raises: a $36 million Series D by SuperSonic Imagine SA (ultrasound) [See Deal], a $25 million Series Cby Topera Medical Inc. (3-D cardio display) [See Deal], and a $17 million Series D from ViewRay Inc. (MRI-guided cancer radiotherapy). [See Deal]

Exhibit 1